The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review: Fid-Bau Portal

The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review

Ezhumalai, Babu / Modi, Ranjan / Panchanatham, Manokar / Kaliyamoorthy, Dhamodaran

Zugriff

Download

Seitennavigation

Dokumentinformationen

Ähnliche Titel

Exportieren, teilen und zitieren

The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review

Ezhumalai, Babu / Modi, Ranjan / Panchanatham, Manokar / Kaliyamoorthy, Dhamodaran

The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review

Ezhumalai, Babu / Modi, Ranjan / Panchanatham, Manokar / Kaliyamoorthy, Dhamodaran

Zugriff

Download

Seitennavigation

Dokumentinformationen

Ähnliche Titel

Exportieren, teilen und zitieren

Dokumentinformationen

Titel:

The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review

Weitere Titelangaben:

Indian Heart Journal

Beteiligte:

Ezhumalai, Babu (Autor:in) / Modi, Ranjan (Autor:in) / Panchanatham, Manokar (Autor:in) / Kaliyamoorthy, Dhamodaran (Autor:in)

Erschienen in:

Indian Heart Journal ; 76 ; 229-239

Erscheinungsdatum:

01.07.2024

ISSN:

0019-4832

DOI:

https://doi.org/10.1016/j.ihj.2024.07.005